Literature DB >> 7460092

Stability and several physical properties of amorphous and crystalline form of indomethacin.

H Imaizumi, N Nambu, T Nagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7460092     DOI： 10.1248/cpb.28.2565

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  18 in total

1.  What is the true solubility advantage for amorphous pharmaceuticals?

Authors:  B C Hancock; M Parks
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Influence of processing-induced phase transformations on the dissolution of theophylline tablets.

Authors:  Smita Debnath; Raj Suryanarayanan
Journal:  AAPS PharmSciTech       Date:  2004-02-12       Impact factor: 3.246

3.  Quantification of crystallinity in substantially amorphous materials by synchrotron X-ray powder diffractometry.

Authors:  Cletus Nunes; Arumugam Mahendrasingam; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

4.  Mechanical activation of pharmaceutical systems.

Authors:  R Hüttenrauch; S Fricke; P Zielke
Journal:  Pharm Res       Date:  1985-11       Impact factor: 4.200

5.  Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis.

Authors:  V Andronis; G Zografi
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

6.  Topical Developments in High-Field Dynamic Nuclear Polarization.

Authors:  Vladimir K Michaelis; Ta-Chung Ong; Matthew K Kiesewetter; Derik K Frantz; Joseph J Walish; Enrico Ravera; Claudio Luchinat; Timothy M Swager; Robert G Griffin
Journal:  Isr J Chem       Date:  2014-02-13       Impact factor: 3.333

7.  In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound.

Authors:  Po-Chang Chiang; Yong Cui; Yingqing Ran; Joe Lubach; Kang-Jye Chou; Linda Bao; Wei Jia; Hank La; Jonathan Hau; Amy Sambrone; Ann Qin; Yuzhong Deng; Harvey Wong
Journal:  AAPS J       Date:  2013-03-02       Impact factor: 4.009

8.  Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization.

Authors:  T Matsumoto; G Zografi
Journal:  Pharm Res       Date:  1999-11       Impact factor: 4.200

9.  Non-isothermal and isothermal crystallization of sucrose from the amorphous state.

Authors:  A Saleki-Gerhardt; G Zografi
Journal:  Pharm Res       Date:  1994-08       Impact factor: 4.200

10.  The effect of low concentrations of molecularly dispersed poly(vinylpyrrolidone) on indomethacin crystallization from the amorphous state.

Authors:  Kieran J Crowley; George Zografi
Journal:  Pharm Res       Date:  2003-09       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.